PMCPA Case Library

1,752 PMCPA Rulings.
Every One Analysed.

The only structured, searchable PMCPA case library in the UK. Expert video walkthroughs, podcast episodes, and MCQ assessments on every ruling — so you understand why companies breach the Code, not just that they did.

▶ Video analysis per case
🎧 Podcast per case
✍ MCQ + CPD certificate
🔒 From £299/year
1752+
Case Studies
5 min
Per Video
5 pts
Per Case Passed
8
Themes
📚
Subscribe for full case library access
Read free summaries below, or subscribe to unlock expert video walkthroughs, podcast audio and CPD certificates.
Sign in See plans ↓
Free — Browsing
✓ Browse all 1752+ case titles
✓ Filter by theme & therapy area
✓ See case reference, company & outcome
✗ Search by company or clause
✗ Video walkthroughs
✗ Podcast episodes
✗ MCQ assessments & CPD certificates
Subscribed — Full Access
✓ Search by company, clause & case ref
✓ Expert video walkthrough per case
✓ Podcast episode per case
✓ MCQ quiz — 5 CPD points per pass
✓ Personalised CPD completion certificate
✓ New cases added monthly
Subscribe from £299/year →
Search by company, clause, case reference... 🔒
All (1752) Social Media & Digital (720) HCP Hospitality & Meetings (431) Data & Publications (321) Off-label Promotion (219) Patient Organisations (44) Transfers of Value (9) Promotional Material (4) Samples & Gifts (2)
Therapy Area: All areas Other (360) Oncology (218) Cardiovascular (189) Respiratory (178) CNS & Neurology (169) Infectious Diseases (115) Diabetes (114) Rare Diseases (104) Immunology & Rheumatology (84) Dermatology (67) Obesity & Weight Management (63) Musculoskeletal & Bone (60) Ophthalmology (31)
Showing 720 results · Social Media & Digital  · Clear
🔒 Subscribers only
AUTH/3568/10/21
Social Media & Digital Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Roche
Roche made a voluntary admission about a certified promotional leavepiece for Gazyvaro (obinutuzumab) (ref M-GB-00000509), described as intended for haematology specialist nurses.A chart on page 6 …
Clauses: 9.1
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3490/3/21
Social Media & Digital Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Britannia Pharmaceuticals
In responding to another PMCPA case (AUTH/3355/5/20), Britannia Pharmaceuticals Ltd made a voluntary admission that it had failed to publish details about certain investigator-led trials.Under Para…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3509/5/21
Social Media & Digital Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
Tillotts
An anonymous complainant challenged a BMJ advertisement (ref EO-00328, April 2021) about Tillotts Pharma UK acquiring Dificlir (fidaxomicin) for Clostridioides difficile infections.The complainant …
Clauses: 9.1,4.2
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3489/3/21
Social Media & Digital Upheld 🏥 Other ▶ Video 🎙 Podcast
Otsuka Europe
Otsuka Pharmaceutical Europe made a voluntary admission about delays in notifying affiliates of an updated Samsca (tolvaptan) summary of product characteristics (SPC/SmPC) and associated prescribin…
Clauses: 9.1,9.2
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3493/3/21
Social Media & Digital Upheld 🏥 Ophthalmology ▶ Video 🎙 Podcast
AbbVie
A complainant provided screenshots alleging a named senior UK employee of AbbVie had promoted Durysta (sustained release bimatoprost implant) on LinkedIn.The employee ‘liked’ a LinkedIn post by…
Clauses: 9.1,9.2,26.1
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3483/3/21
Social Media & Digital Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Eli Lilly
A UK health professional complained about a LinkedIn post about an investigational medicine being ‘liked’ by UK-based staff, allegedly promoting it to the UK public.The post was on the Eli Lill…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3494/3/21
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Bristol-Myers Squibb
An anonymous, contactable complainant alleged a senior named Bristol-Myers Squibb (BMS) UK employee promoted Opdivo (nivolumab) and Yervoy (ipilimumab) on LinkedIn by ‘liking’ a post from a sen…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3533/7/21
Social Media & Digital Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Allergan
An anonymous complainant alleged a named senior Allergan UK employee (500+ LinkedIn connections) repeatedly ‘liked’/shared content visible to UK health professionals and members of the public.P…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3531/7/21
Social Media & Digital Not Upheld 🏥 Ophthalmology ▶ Video 🎙 Podcast
Anonymous v Novartis
An anonymous, non-contactable complainant (described as an optometrist) challenged Novartis promotional materials for Lucentis (ranibizumab) seen in UK ophthalmic journals and on a Novartis HCP web…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3528/6/21
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Advanced Accelerator Applications
An anonymous complainant (a doctor) received three email invitations in April 2021 (15, 22 and 27) from a third party promoting an online CPD activity about PSMA-targeted therapy for metastatic cas…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3565/10/21
Social Media & Digital Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Otsuka Europe & Otsuka UK
Otsuka Pharmaceutical Europe Limited (AUTH/3565/10/21) and Otsuka Pharmaceuticals (UK) Limited (AUTH/3566/10/21) made a joint voluntary admission about incorrect prescribing information (PI) for Ab…
Clauses: 4.1
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3542/7/21
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Daiichi-Sankyo
An anonymous (initially contactable) health professional complained about Daiichi-Sankyo UK promotional materials in Guidelines in practice (hard copy and digital).The hard copy journal ad for Nile…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3557/9/21
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
GlaxoSmithKline
An anonymous, non-contactable complainant (pharmacist in a primary care network) challenged GSK’s promotion of Seretide Evohaler (salmeterol/fluticasone propionate).The complaint focused on a GSK…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3563/9/21
Social Media & Digital Not Upheld 🏥 Cardiovascular ▶ Video 🎙 Podcast
Bristol-Myers Squibb & Pfizer
A health professional complainant accessed the Eliquis.co.uk health professional (HCP) section via the ‘I am a HCP’ tab.They objected to the repeated banner headline “Choose Eliquis”, alleg…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3583/11/21
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Instagram ‘awards’ story featuring Itulazax imagery
A contactable complainant (agency employee) complained about Instagram advertisements for Itulazax (Betula verrucosa) posted by a UK-based creative agency and said the public could view readable pr…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3587/12/21
Social Media & Digital Not Upheld 🏥 Respiratory ▶ Video 🎙 Podcast
AstraZeneca
An anonymous complainant (self-described health professional) complained about a Symbicort (budesonide formoterol fumarate dihydrate) cost-calculator webpage on medicines.astrazeneca.co.uk.The comp…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3523/6/21
Social Media & Digital Not Upheld 🏥 Obesity & Weight Management ▶ Video 🎙 Podcast
Novo Nordisk
A UK health professional complained about a LinkedIn post made (June 2021) by an individual contracted to work for Novo Nordisk A/S (Denmark) via a third-party talent acquisition agency.The post st…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3541/7/21
Social Media & Digital Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Roche Resources website
An anonymous health professional complained about alleged errors/omissions across several pages on Roche Products Ltd’s “Roche Resources” website (HCP-facing).Medicines landing page: alleged …
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3550/7/21
Social Media & Digital Not Upheld 🏥 CNS & Neurology ▶ Video 🎙 Podcast
Lundbeck
A health professional complained that Lundbeck promoted Vyepti (eptinezumab) before UK marketing authorisation via a session at the Migraine Trust International Symposium (MTIS) virtual event (Oct …
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3552/8/21
Social Media & Digital Not Upheld 🏥 Other ▶ Video 🎙 Podcast
Roche Resources website
An anonymous health professional complained about the mobile version of Roche’s HCP-facing “Roche Resources” website (rocheresources.co.uk), saying it differed from desktop and appeared not t…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3554/8/21
Social Media & Digital Upheld 🏥 Dermatology ▶ Video 🎙 Podcast
UCB
An anonymous, non-contactable complainant (member of the public/media) complained about a LinkedIn post about Bimzelx (bimekizumab) made by a named organisation, which was shown as being ‘liked�…
Clauses: 9.1,9.2,26.1
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3569/10/21
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Pierre Fabre
A complainant (member of the public/media) alleged that Nerlynx (neratinib maleate) had been promoted to the public.The allegation related to an advertising/marketing agency using materials includi…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3570/10/21
Social Media & Digital Not Upheld 🏥 Oncology ▶ Video 🎙 Podcast
Stallergenes Greer
A health professional complained about a Stallergenes Greer corporate LinkedIn post which referenced a sublingual house dust mite allergen immunotherapy tablet and listed brand names used in differ…
Clauses: NONE
2021 🔒 Subscribe
🔒 Subscribers only
AUTH/3518/5/21
Social Media & Digital Not Upheld 🏥 Infectious Diseases ▶ Video 🎙 Podcast
AstraZeneca press releases on COVID-19 vaccine
A member of the public complained about two AstraZeneca press releases hosted on AstraZeneca UK Limited’s website (dated 30 December 2020 and 18 March 2021).The complainant alleged the vaccine wa…
Clauses: NONE
2021 🔒 Subscribe
← Prev 8 9 10 11 12 13 14 Next → Page 11 of 30 — 720 cases
Unlock the Full Case Library
Annual subscription — instant access, cancel anytime.
🏆
The only PMCPA case library of its kind
No other provider publishes a structured, searchable library of PMCPA rulings with video and podcast. A single half-day compliance workshop from a specialist provider typically costs £499+ — for one session. Individual access here is £299 for a full year of 2,000+ cases.
PMCPA Case Library — Team (100 seats)
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
Enquire for bulk pricing →
Individual
For a single learner
£299
per year
Less than a single half-day workshop
  • 1 user seat
  • All 1752+ case studies
  • Video + podcast per case
  • MCQ quiz per case
  • 5 points per case passed
  • New cases added monthly
Create account or sign in to buy
Most Popular
Team 5
Up to 5 team members
£999
per year (£200/seat)
£200/person — the most cost-effective team option
  • 5 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • New cases added monthly
  • Admin management portal
Create account or sign in to buy
Team 25+
25+ team members
Custom pricing
tailored to your team size
Bulk pricing available — contact us for a quote
  • 25 user seats
  • All case studies included
  • Video, podcast & MCQ per case
  • Team progress dashboard
  • Bulk seat management
  • Priority support
Enquire for bulk pricing →

Questions? Email [email protected]  ·  14-day money-back guarantee  ·  Annual subscription, auto-renews